Literatura científica selecionada sobre o tema "Dox-Induced Cardiotoxicity"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Dox-Induced Cardiotoxicity".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Dox-Induced Cardiotoxicity"
Sumneang, Natticha, Pongpan Tanajak e Thura Tun Oo. "Toll-like Receptor 4 Inflammatory Perspective on Doxorubicin-Induced Cardiotoxicity". Molecules 28, n.º 11 (24 de maio de 2023): 4294. http://dx.doi.org/10.3390/molecules28114294.
Texto completo da fonteAmmar, El-Sayed M., Shehta A. Said, Ghada M. Suddek e Sally L. El-Damarawy. "Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats". Canadian Journal of Physiology and Pharmacology 89, n.º 4 (abril de 2011): 269–76. http://dx.doi.org/10.1139/y11-020.
Texto completo da fonteHamaamin, Karmand Salih, e Tavga Ahmed Aziz. "Doxorubicin-Induced Cardiotoxicity: Mechanisms and Management". Al-Rafidain Journal of Medical Sciences ( ISSN: 2789-3219 ) 3 (10 de dezembro de 2022): 87–97. http://dx.doi.org/10.54133/ajms.v3i.90.
Texto completo da fonteZheng, Dong, Yi Zhang, Ming Zheng, Ting Cao, Grace Wang, Lulu Zhang, Rui Ni et al. "Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity". Clinical Science 133, n.º 13 (julho de 2019): 1505–21. http://dx.doi.org/10.1042/cs20181022.
Texto completo da fonteZhang, Wei, Zhixing Fan, Fengyuan Wang, Lin Yin, Jinchun Wu, Dengke Li, Siwei Song, Xi Wang, Yanhong Tang e Congxin Huang. "Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3". Oxidative Medicine and Cellular Longevity 2023 (14 de janeiro de 2023): 1–23. http://dx.doi.org/10.1155/2023/9966355.
Texto completo da fonteMao, Jin Ning, Ai Jun Li, Liang Ping Zhao, Lan Gao, Wei Ting Xu, Xiao Su Hong, Wen Ping Jiang e Jian Chang Chen. "PEG-PLGA Nanoparticles Entrapping Doxorubicin Reduced Doxorubicin-Induced Cardiotoxicity in Rats". Advanced Materials Research 912-914 (abril de 2014): 263–68. http://dx.doi.org/10.4028/www.scientific.net/amr.912-914.263.
Texto completo da fonteManeechote, Chayodom, Siriporn C. Chattipakorn e Nipon Chattipakorn. "Recent Advances in Mitochondrial Fission/Fusion-Targeted Therapy in Doxorubicin-Induced Cardiotoxicity". Pharmaceutics 15, n.º 4 (7 de abril de 2023): 1182. http://dx.doi.org/10.3390/pharmaceutics15041182.
Texto completo da fonteKitakata, Hiroki, Jin Endo, Hidehiko Ikura, Hidenori Moriyama, Kohsuke Shirakawa, Yoshinori Katsumata e Motoaki Sano. "Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis". International Journal of Molecular Sciences 23, n.º 3 (26 de janeiro de 2022): 1414. http://dx.doi.org/10.3390/ijms23031414.
Texto completo da fonteda Cunha Menezes Souza, Leonardo, Meng Chen, Yuji Ikeno, Daisy Maria Fávero Salvadori e Yidong Bai. "The implications of mitochondria in doxorubicin treatment of cancer in the context of traditional and modern medicine". Traditional Medicine and Modern Medicine 03, n.º 04 (dezembro de 2020): 239–54. http://dx.doi.org/10.1142/s2575900020300076.
Texto completo da fonteJiang, Lai, Yanping Gong, Yida Hu, Yangyang You, Jiawu Wang, Zhetao Zhang, Zeyuan Wei e Chaoliang Tang. "Peroxiredoxin-1 Overexpression Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Oxidative Stress and Cardiomyocyte Apoptosis". Oxidative Medicine and Cellular Longevity 2020 (29 de julho de 2020): 1–11. http://dx.doi.org/10.1155/2020/2405135.
Texto completo da fonteTeses / dissertações sobre o assunto "Dox-Induced Cardiotoxicity"
Mammadova, Aynura. "The role of MEIS inhibitors in cardiac regeneration and protection". Electronic Thesis or Diss., Strasbourg, 2024. http://www.theses.fr/2024STRAJ006.
Texto completo da fonteThe TALE-type homeobox gene MEIS1 has been identified as a critical factor in controlling the cell cycle arrest of cardiomyocytes, presenting itself as an attractive target for therapy. Our latest investigations have revealed the potential of MEIS1 suppression to promote the regeneration of cardiomyocytes. Further experiments with neonatal cardiomyocytes showed that two innovative small molecules, MEISi-1 and MEISi-2, enhanced the proliferation (Ph3+TnnT cells) and cytokinesis (AuroraB+TnnT cells) of these cells. Suppressing MEIS1 activity resulted in the diminished expression of its target genes and the inhibitors of cyclin-dependent kinases. Additionally, this research extended to cultivating human induced pluripotent stem cells (hiPSCs) into cardiomyocytes to examine the impact of MEIS1 suppression, which notably did not compromise their viability. Intriguingly, short-term and long-term treatment with MEISi in hiPSCs led to significant elevation in essential cardiac-specific gene expression, notably influencing cardiac mesoderm and progenitor cells, and positioning MEIS1 inhibitors as crucial modulators of cardiac gene expression. Our findings indicate that MEIS inhibitors can provide protection against the acute cardiotoxic effects of doxorubicin (DOX) in Wistar rats, as evidenced by the maintained structure of cardiac tissue and unchanged levels of fibrosis or collagen. qPCR analyses further confirmed the upregulation of cardiac progenitor genes and a balance in anti-apoptotic and ROS-related gene expression, hinting at the protective role of MEIS inhibitors against DOX-induced damage without influencing fibrosis. These results highlight the therapeutic potential of MEIS inhibitors in regenerative cardiology, suggesting their utility in enhancing cardiomyocyte renewal and offering protection against cardiotoxicity
Trabalhos de conferências sobre o assunto "Dox-Induced Cardiotoxicity"
Tao, Rong-Hua, Masato Kobayashi, Fei Wang, Yuanzheng Yang e Eugenie S. Kleinerman. "Abstract 5422: Dissecting the mechanism of exercise-mediated protection of Dox-induced cardiotoxicity". In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-5422.
Texto completo da fonte